Compare BCTX & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCTX | RMTI |
|---|---|---|
| Founded | 2014 | 1994 |
| Country | Canada | United States |
| Employees | 4 | 300 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 26.7M |
| IPO Year | 2025 | 2022 |
| Metric | BCTX | RMTI |
|---|---|---|
| Price | $3.01 | $0.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $40.00 | $2.00 |
| AVG Volume (30 Days) | 190.0K | ★ 337.2K |
| Earning Date | 06-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $69,258,000.00 |
| Revenue This Year | N/A | $8.64 |
| Revenue Next Year | $380.95 | $8.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.61 | $0.60 |
| 52 Week High | $14.68 | $2.10 |
| Indicator | BCTX | RMTI |
|---|---|---|
| Relative Strength Index (RSI) | 42.06 | 43.03 |
| Support Level | $2.98 | $0.60 |
| Resistance Level | $4.38 | $1.02 |
| Average True Range (ATR) | 0.21 | 0.04 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 48.22 | 62.51 |
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.